In this study we are estimating the risk of pancreatic ductal adenocarcinoma among individuals NOD (New Onset Diabetes) Protocol defined hyperglycemia by study status (enrolled, not enrolled, not recruited). We will also participate in a national multi-site effort to build a biorepository that will be used to develop and/or test biomarkers for early detection of pancreatic cancer.
A Prospective Study to Establish a New Onset Diabetes (NOD) Cohort
Investigator: Van Den Eeden, Stephen
Funder: National Institute of Diabetes and Digestive and Kidney Diseases
